Details

Autor(en) / Beteiligte

• Sugarbaker, David J
• Richards, William G
• Gordon, Gavin J
• Dong, Lingsheng
• De Rienzo, Assunta
• Maulik, Gautam
• Glickman, Jonathan N
• Chirieac, Lucian R
• Hartman, Mor-Li
• Taillon, Bruce E
• Du, Lei
• Bouffard, Pascal
• Kingsmore, Stephen F
• Miller, Neil A
• Farmer, Andrew D
• Jensen, Roderick V
• Gullans, Steven R
• Bueno, Raphael

Titel

Transcriptome sequencing of malignant pleural mesothelioma tumors

Ist Teil von

• Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (9), p.3521-3526

Ort / Verlag

United States: National Academy of Sciences

Erscheinungsjahr

2008

Link zum Volltext

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• Cancers arise by the gradual accumulation of mutations in multiple genes. We now use shotgun pyrosequencing to characterize RNA mutations and expression levels unique to malignant pleural mesotheliomas (MPMs) and not present in control tissues. On average, 266 Mb of cDNA were sequenced from each of four MPMs, from a control pulmonary adenocarcinoma (ADCA), and from normal lung tissue. Previously observed differences in MPM RNA expression levels were confirmed. Point mutations were identified by using criteria that require the presence of the mutation in at least four reads and in both cDNA strands and the absence of the mutation from sequence databases, normal adjacent tissues, and other controls. In the four MPMs, 15 nonsynonymous mutations were discovered: 7 were point mutations, 3 were deletions, 4 were exclusively expressed as a consequence of imputed epigenetic silencing, and 1 was putatively expressed as a consequence of RNA editing. Notably, each MPM had a different mutation profile, and no mutated gene was previously implicated in MPM. Of the seven point mutations, three were observed in at least one tumor from 49 other MPM patients. The mutations were in genes that could be causally related to cancer and included XRCC6, PDZK1IP1, ACTR1A, and AVEN.